Pediatr. praxi. 2014;15(2):86-88

Streptococcus agalactiae as a cause of reccurent septicemia in an immuno-competent infant

MUDr.Radka Drápalová1, MUDr.Eva Klásková2, MUDr.Pavla Fabulová2, prof.MUDr.František Kopřiva, Ph.D.2, prof.MUDr.Vladimír Mihál, CSc.2
1 Dětská klinika FN Olomouc
2 Dětská klinika LF UP a FN Olomouc

Neonatal and infantile sepsis are the most redoubtable problems in neonatology and pediatrics. In this article we discuss the most

frequent cause of neonatal sepsis, which is Streptococcus agalactiae, group B streptococcus (GBS). We present a case report of an infant

with recurrent sepsis caused by GBS. In the discussion we mention the pathogenetic mechanisms of recurrent GBS invasive infections

and possible prophylactic follow-up antibiotic treatment.

Keywords: neonatal sepsis, Streptococcus agalactiae (GBS), GBS-positive mothers

Published: April 20, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drápalová R, Klásková E, Fabulová P, Kopřiva F, Mihál V. Streptococcus agalactiae as a cause of reccurent septicemia in an immuno-competent infant. Pediatr. praxi. 2014;15(2):86-88.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Berner R. Group B streptococci during pregnancy and infancy. Curr Opin Infect Dis 2002; 15(3): 307-313. Go to original source... Go to PubMed...
    2. Puopolo KM, Group B streptococcal infection in neonates and young infants. www.uptodate.com/this topic last updated: X 10, 2013.
    3. Gagneur A, Héry-Arnaud G, Croly-Labourdette S, et al. Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr 2009; 168(9): 1155-1158. Go to original source... Go to PubMed...
    4. Soukka H, Rantakokko-Jalava K, Vähäkuopus S, Ruuskanen O. Three distinct episodes of GBS septicemia in a healthy newborn during the first month of life. Eur J Pediatr 2010; 169(10): 1275-1277. Go to original source... Go to PubMed...
    5. Shoda T, Miyagi N, Shirai K, Furushima W, et al. Double recurrence of group B streptococcus bacteremia in an immunocompetent infant. Pediatr Int 2012; 54(5): 701-703. Go to original source... Go to PubMed...
    6. Atkins JT, Heresi GP, Coque TM, Baker CJ. Recurrent group B streptococcal disease in infants: Who should receive rifampin? J Pediatr 1998; 132(3): 537-539. Go to original source... Go to PubMed...
    7. Barshak MB, Madoff LC. Group B streptococcal infections in nonpregnant adults. www.uptodate.com/this topic last updated: VI 19, 2013.
    8. Green PA, Singh KV, Murray BE, Baker CJ. Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects. J Pediatr 1994; 125(6): 931-938. Go to original source... Go to PubMed...
    9. Fernandez M, Rench MA, Albanyan EA, et al. Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J 2001; 20(4): 371-376. Go to original source... Go to PubMed...
    10. Denning DW, Bressack M, Troup NJ, Tompkins LS. Infant with two relapses of group B streptococcal sepsis documented by DNA restriction enzyme analysis. Pediatr Infect Dis J 1988; 7(10): 729-732. Go to original source... Go to PubMed...
    11. Millard DD, Shulman ST, Yogev R. Rifampin and for the elimination of group B streptococci in nasally colonized infant rats. Pediatr Res 1985; 19(11): 1183-1186. Go to original source... Go to PubMed...
    12. Paoletti LC, Madow LC, Baker CJ. Vaccines for the prevention of group B streptococcal disease. www.uptodate.com/ this topic last updated: XII 20, 2013.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.